Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» insomnia
insomnia
Pear Therapeutics Looks For A Buyer As It Struggles To Get Paid For Prescription Apps
Forbes
Sun, 03/19/23 - 01:40 pm
Pear Therapeutics
digital therapeutics
FDA
Medtech
insomnia
M&A
ResMed Strengthens Sleep Portfolio with Mementor Acquisition
Medical Devices and Diagnostics Industry
Wed, 08/3/22 - 09:36 pm
ResMed
Mementor
insomnia
M&A
digital therapeutics
Idorsia's recently approved insomnia drug Quviviq hits the shelves
Bizjournals
Wed, 05/4/22 - 05:43 pm
Idorsia
drug launches
insomnia
Quviviq
Idorsia scores FDA go-ahead for insomnia drug Quviviq to rival Merck’s Belsomra, Eisai’s Dayvigo
Fierce Pharma
Mon, 01/10/22 - 11:37 pm
Idorsia
Quviviq
insomnia
FDA
Merck
Belsomra
Idorsia hoping to make its dreams come true with a new insomnia alliance
Fierce Pharma
Tue, 12/14/21 - 11:06 am
Idorsia
insomnia
pharma marketing
daridorexant
Chasing Merck, Eisai launches insomnia drug Dayvigo in Japan
Pharmaforum
Tue, 07/7/20 - 10:40 am
Eisai
Dayvigo
Japan
insomnia
Merck
Belsomra
Second PhIII study for Idorsia's sleep drug returns positive results, but also raises new questions
Endpoints
Tue, 07/7/20 - 10:35 am
Idorsia
daridorexant
insomnia
clinical trials
Idorsia's rival to Merck's insomnia drug clears phase 3 test
Fierce Biotech
Mon, 04/20/20 - 10:47 am
Idorsia
Merck
insomnia
clinical trials
JNJ
daridorexant
Belsorma
Prescriptions for antidepressants, anti-anxiety, anti-insomnia drugs jumps 21% post COVID-19
Fierce Healthcare
Fri, 04/17/20 - 08:47 pm
Express Scripts
COVID-19
pandemic
prescription data
antidepressants
anxiety
insomnia
Merck's Insomnia Drug Approved for Alzheimer's Patients
Motley Fool
Mon, 02/3/20 - 11:48 pm
Merck
FDA
Alzheimer's disease
Belsomra
insomnia
FDA clears Eisai’s insomnia drug Dayvigo
Pharmaforum
Mon, 12/30/19 - 11:01 am
FDA
Eisai
Dayvigo
insomnia
Merck
Belsomra
Eisai preps for launch with insomnia med Dayvigo after buying out Purdue
Fierce Pharma
Mon, 12/23/19 - 11:36 pm
Eisai
Purdue
FDA
drug launches
insomnia
Dayvigo
Imbrium initiates phase 2 study of IMB-115 in insomnia associated with alcohol cessation
Pharmaceutical Business Review
Wed, 06/26/19 - 10:33 am
Imbrium Therapeutics
clinical trials
IMB-115
insomnia
IAAC
Better than Ambien? Minerva soars on PhIIb update on seltorexant for insomnia
Endpoints
Mon, 06/24/19 - 11:33 am
Minerva
insomnia
clinical trials
seltorexant
Merck Ready to Submit Belsomra to FDA for Alzheimer's Insomnia
BioSpace
Tue, 05/7/19 - 11:50 am
Merck
Belsomra
insomnia
Alzheimer's disease
Eisai buys Purdue stake in insomnia drug as PDUFA date nears
Fierce Biotech
Wed, 05/1/19 - 10:46 am
Eisai
Purdue Pharma
insomnia
lemborexant
FDA
FDA adds boxed warnings to insomnia medicines following injuries, deaths
Endpoints
Wed, 05/1/19 - 10:31 am
FDA
insomnia
black box
Lunesta
Sonata
Ambien
Ambien CR
Edluar
Intermezzo
Zolpimist
Sleep Well, Wake Up Alert: Eisai and Purdue's Lemborexant Positive in Phase III Trial for Insomnia
BioSpace
Wed, 10/17/18 - 10:23 am
Eisai
Purdue Pharma
lemborexant
insomnia
After split from Actelion, Idorsia CEO plans to raise more cash in 2019
Yahoo/Reuters
Mon, 06/18/18 - 09:47 am
Indorsia
Actelion
JNJ
insomnia
Eisai, Purdue reveal eye-opening data for sleep drug lemborexant
Fierce Biotech
Wed, 06/6/18 - 09:38 am
Eisai
Purdue Pharma
lemborexant
sleep disorders
clinical trials
insomnia
Pages
1
2
3
4
5
6
7
next ›
last »